Advancing Together. Building Possibilities.
Evolving With Our Customers
Our Halle/Westfalen facility is currently undergoing a $100 million expansion. This expansion builds upon previous investments to add both manufacturing capacity and new technologies aimed at staying at the forefront of development and manufacturing for leading-edge parenteral products. Simtra BioPharma Solutions will continue to invest in its facilities to meet current and evolving customer needs.
Significant Additions
The new building will span 19,375 square feet (1,800 square meters) and will house additional state-of-the-art equipment. Ground was broken in November 2022, and outside construction is expected to be completed by the end of 2024. Providing flexibility to meet specific customer requirements, the expansion will include a new vial filling line equipped with lyophilizers and a new high-speed prefilled syringe line. Commercial manufacturing is projected to start in Q2 2025 for the syringe filling line and Q1 2026 for the vial filling line.
Expanded Development and Manufacturing Capabilities In Halle/Westfalen, Germany
-
New Vial Filling Line Equipped with Lyophilizers
-
New High-Speed Syringe Line
-
Flexibility to Meet Specific Customer Requirements
Follow Us
Follow us on LinkedIn to stay up to date on our facility expansion in Halle/Westfalen, Germany.